BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 33146385)

  • 1. Patient-Reported Outcomes in Clinical Trials Leading to Cancer Immunotherapy Drug Approvals From 2011 to 2018: A Systematic Review.
    Safa H; Tamil M; Spiess PE; Manley B; Pow-Sang J; Gilbert SM; Safa F; Gonzalez BD; Oswald LB; Semaan A; Diab A; Chahoud J
    J Natl Cancer Inst; 2021 May; 113(5):532-542. PubMed ID: 33146385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 15 years of patient-reported outcomes in clinical trials leading to GU cancer drug approvals: a systematic review on the quality of data reporting and analysis.
    Paravathaneni M; Safa H; Joshi V; Tamil MK; Adashek JJ; Ionescu F; Shah S; Chadha JS; Gilbert S; Manley B; Semaan A; Jim HSL; Kalos D; Kim Y; Spiess PE; Chahoud J
    EClinicalMedicine; 2024 Feb; 68():102413. PubMed ID: 38273886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poor patient-reported outcomes reporting according to CONSORT guidelines in randomized clinical trials evaluating systemic cancer therapy.
    Bylicki O; Gan HK; Joly F; Maillet D; You B; Péron J
    Ann Oncol; 2015 Jan; 26(1):231-237. PubMed ID: 25355720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use and Reporting of Patient-Reported Outcomes in Trials of Palliative Radiotherapy: A Systematic Review.
    Fabian A; Domschikowski J; Letsch A; Schmalz C; Freitag-Wolf S; Dunst J; Krug D
    JAMA Netw Open; 2022 Sep; 5(9):e2231930. PubMed ID: 36136335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-Reported Outcomes in Phase 3 Clinical Trials for Blood Cancers: A Systematic Review.
    Patel K; Ivanov A; Jocelyn T; Hantel A; Garcia JS; Abel GA
    JAMA Netw Open; 2024 Jun; 7(6):e2414425. PubMed ID: 38829615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inclusion of older patients with cancer in randomised controlled trials with patient-reported outcomes: a systematic review.
    Sparano F; Aaronson NK; Sprangers MAG; Fayers P; Pusic A; Kieffer JM; Cottone F; Rees J; Pezold M; Anota A; Charton E; Vignetti M; Wan C; Blazeby J; Efficace F
    BMJ Support Palliat Care; 2019 Dec; 9(4):451-463. PubMed ID: 31719051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-reported outcomes in randomised clinical trials of bladder cancer: an updated systematic review.
    Van Hemelrijck M; Sparano F; Josephs D; Sprangers M; Cottone F; Efficace F
    BMC Urol; 2019 Sep; 19(1):86. PubMed ID: 31521149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of patient-reported outcome reporting in randomised controlled trials of haematological malignancies according to international quality standards: a systematic review.
    Chakraborty R; Cannella L; Cottone F; Efficace F
    Lancet Haematol; 2020 Dec; 7(12):e892-e901. PubMed ID: 33242446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statistical analysis of patient-reported outcome data in randomised controlled trials of locally advanced and metastatic breast cancer: a systematic review.
    Pe M; Dorme L; Coens C; Basch E; Calvert M; Campbell A; Cleeland C; Cocks K; Collette L; Dirven L; Dueck AC; Devlin N; Flechtner HH; Gotay C; Griebsch I; Groenvold M; King M; Koller M; Malone DC; Martinelli F; Mitchell SA; Musoro JZ; Oliver K; Piault-Louis E; Piccart M; Pimentel FL; Quinten C; Reijneveld JC; Sloan J; Velikova G; Bottomley A;
    Lancet Oncol; 2018 Sep; 19(9):e459-e469. PubMed ID: 30191850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-reported outcomes in randomized clinical trials of systemic therapy for advanced soft tissue sarcomas in adults: A systematic review.
    Roets E; van der Graaf W; van Riet BHG; Haas RL; Younger E; Sparano F; Wilson R; van der Mierden S; Steeghs N; Efficace F; Husson O
    Crit Rev Oncol Hematol; 2024 May; 197():104345. PubMed ID: 38582227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials-Innovative Medicines Initiative (SISAQOL-IMI): stakeholder views, objectives, and procedures.
    Pe M; Alanya A; Falk RS; Amdal CD; Bjordal K; Chang J; Cislo P; Coens C; Dirven L; Speck RM; Fitzgerald K; Galinsky J; Giesinger JM; Holzner B; Le Cessie S; O'Connor D; Oliver K; Pawar V; Quinten C; Schlichting M; Ren J; Roychoudhury S; Taphoorn MJB; Velikova G; Wintner LM; Griebsch I; Bottomley A;
    Lancet Oncol; 2023 Jun; 24(6):e270-e283. PubMed ID: 37269858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-reported outcomes in head and neck and thyroid cancer randomised controlled trials: A systematic review of completeness of reporting and impact on interpretation.
    Mercieca-Bebber RL; Perreca A; King M; Macann A; Whale K; Soldati S; Jacobs M; Efficace F
    Eur J Cancer; 2016 Mar; 56():144-161. PubMed ID: 26851406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harnessing the patient voice in prostate cancer research: Systematic review on the use of patient-reported outcomes in randomized controlled trials to support clinical decision-making.
    Van Hemelrijck M; Sparano F; Moris L; Beyer K; Cottone F; Sprangers M; Efficace F
    Cancer Med; 2020 Jun; 9(12):4039-4058. PubMed ID: 32333639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating Trends in the Quality of Reporting of Patient-Reported Outcomes in Oncology Over Time: Analysis of 631 Randomized Controlled Trials Published Between 2004 and 2019.
    Efficace F; Giesinger JM; Cella D; Cottone F; Sparano F; Vignetti M; Aaronson NK
    Value Health; 2021 Dec; 24(12):1715-1719. PubMed ID: 34838268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of patient-reported outcomes in advanced breast cancer clinical trials: a review of the published literature.
    Turner-Bowker DM; Hao Y; Foley C; Galipeau N; Mazar I; Krohe M; Globe D; Shields AL
    Curr Med Res Opin; 2016 Oct; 32(10):1709-17. PubMed ID: 27331272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moving forward toward standardizing analysis of quality of life data in randomized cancer clinical trials.
    Bottomley A; Pe M; Sloan J; Basch E; Bonnetain F; Calvert M; Campbell A; Cleeland C; Cocks K; Collette L; Dueck AC; Devlin N; Flechtner HH; Gotay C; Greimel E; Griebsch I; Groenvold M; Hamel JF; King M; Kluetz PG; Koller M; Malone DC; Martinelli F; Mitchell SA; Moinpour CM; Musoro JZ; O'Connor D; Oliver K; Piault-Louis E; Piccart M; Pimentel FL; Quinten C; Reijneveld JC; Schürmann C; Smith AW; Soltys KM; Sridhara R; Taphoorn MJB; Velikova G; Coens C
    Clin Trials; 2018 Dec; 15(6):624-630. PubMed ID: 30141714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of patient-reported outcome (PRO) data from clinical trials: a systematic review and critical analysis.
    Rivera SC; Kyte DG; Aiyegbusi OL; Slade AL; McMullan C; Calvert MJ
    Health Qual Life Outcomes; 2019 Oct; 17(1):156. PubMed ID: 31619266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the collection and reporting of patient-reported outcome data in interventional cancer trials: a single institution, retrospective systematic evaluation.
    Lidington E; Hogan H; Gandolfi A; Lawrence J; Younger E; Cho H; Peckitt C; Mohammed K; Matharu S; Scerri L; Husson O; Cruickshank S; Turner R; Wedlake L
    J Patient Rep Outcomes; 2022 Dec; 6(1):128. PubMed ID: 36547735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of patient-reported outcomes in oncology clinical trials using immune checkpoint inhibitors: A systematic review.
    Malone E; Barua R; Meti N; Li X; Fazelzad R; Hansen AR
    Cancer Med; 2021 Aug; 10(15):5031-5040. PubMed ID: 34184416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.